Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.31 $4.00 Thursday, 9th May 2024 CYCC stock ended at $2.31. This is 0.431% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 14.48% from a day low at $2.27 to a day high of $2.60.
90 days $1.31 $4.00
52 weeks $1.31 $13.20

Historical Cyclacel Pharmaceuticals prices

Date Open High Low Close Volume
Sep 15, 2016 $4.95 $5.15 $4.83 $5.09 41 500
Sep 14, 2016 $4.91 $5.02 $4.81 $4.92 26 800
Sep 13, 2016 $5.09 $5.09 $4.80 $4.91 57 000
Sep 12, 2016 $5.07 $5.17 $4.88 $5.08 46 900
Sep 09, 2016 $5.44 $5.48 $5.01 $5.04 101 600
Sep 08, 2016 $5.31 $5.67 $5.23 $5.41 44 700
Sep 07, 2016 $5.26 $5.48 $5.26 $5.28 49 800
Sep 06, 2016 $5.84 $5.84 $5.23 $5.27 219 500
Sep 02, 2016 $5.67 $5.77 $5.53 $5.71 81 300
Sep 01, 2016 $5.61 $5.75 $5.50 $5.71 85 300
Aug 31, 2016 $5.91 $6.01 $5.61 $5.67 241 800
Aug 30, 2016 $6.15 $6.46 $6.03 $6.20 167 300
Aug 29, 2016 $6.56 $6.68 $6.10 $6.20 454 600
Aug 26, 2016 $6.73 $6.85 $6.50 $6.62 150 000
Aug 25, 2016 $6.99 $7.97 $6.80 $6.83 992 600
Aug 24, 2016 $7.22 $7.48 $6.97 $7.05 352 000
Aug 23, 2016 $8.00 $8.19 $6.98 $7.42 955 700
Aug 22, 2016 $8.05 $9.72 $7.86 $8.28 6 366 600
Aug 19, 2016 $7.27 $7.48 $6.69 $6.93 659 100
Aug 18, 2016 $7.77 $8.45 $7.33 $7.51 983 900
Aug 17, 2016 $7.32 $9.13 $6.61 $8.00 4 708 500
Aug 16, 2016 $5.74 $7.52 $5.63 $7.31 1 421 000
Aug 15, 2016 $5.50 $5.82 $5.20 $5.73 628 400
Aug 12, 2016 $5.78 $5.78 $5.01 $5.40 2 939 700
Aug 11, 2016 $4.87 $4.87 $4.21 $4.48 115 700
Click to get the best stock tips daily for free!

About Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-... CYCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT